Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents A protocol for systematic review and meta-analysis

Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents A protocol for systematic review and meta-analysis

<h3>Introduction</h3><p dir="ltr">Existing evidence on the difference in the incidence of tumor lysis syndrome (TLS) in Chronic Lymphocytic Leukemia (CLL) patients receiving novel therapies versus patients receiving conventional therapies is limited and inconclusive. The...

Full description

Saved in:
Bibliographic Details
Main Author: Nancy Kassem (3517106) (author)
Other Authors: Ahmed A. Ghazy (16555849) (author), Mohammad Abu-Tineh (14829313) (author), Nabil E. Omar (16555850) (author), Abdulqadir J. Nashwan (16328993) (author), Prem Chandra (9072038) (author), Rola Ghasoub (16555851) (author), Osama S. AbuTabar (16555854) (author), Mohamed A. Yassin (16322749) (author)
Published: 2020
Subjects:
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Oncology and carcinogenesis
Mathematical sciences
Statistics
chronic lymphocytic leukaemia
conventional chemotherapeutic agents
novel chemotherapeutic agents
tumor lysis syndrome
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items